17 results on '"Herbst, Regina"'
Search Results
2. Alterations of cohesin complex genes in acute myeloid leukemia: differential co-mutations, clinical presentation and impact on outcome
3. Prospective validation of a biomarker-driven response prediction model to romiplostim in lower-risk myelodysplastic neoplasms – results of the EUROPE trial by EMSCO
4. Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years
5. Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
6. Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow-up of 14.4 years
7. Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
8. Impact of PTPN11 mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
9. Double-Blind, Placebo Controlled, Randomized, Multicenter, Phase II Study to Assess the Efficacy of the High Affinity CXCR4 Inhibitor BL-8040 As Addition to Consolidation Therapy in AML By the SAL and OSHO Leukemia Study Groups
10. Mutated IKZF1is an independent marker of adverse risk in acute myeloid leukemia
11. Single Versus Double Induction with "7+3" Containing 60 Versus 90 Mg Daunorubicin for Newly Diagnosed AML: Results from the Randomized Controlled SAL Dauno-Double Trial
12. Correction: Dexa-BEAM versus MIFAP as salvage regimen for recurrent lymphoma: a prospective randomized multicenter phase II trial with a median follow‑up of 14.4 years
13. Additional file 1 of Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations
14. Impact of first-line use of caplacizumab on treatment outcomes in immune thrombotic thrombocytopenic purpura
15. Impact of PTPN11mutations on clinical outcome analyzed in 1529 patients with acute myeloid leukemia
16. Sorafenib or placebo in patients with newly diagnosed acute myeloid leukaemia: long-term follow-up of the randomized controlled SORAML trial
17. Unicentric Retrospective Analysis of 130 Patients with Extramedullary Multiple Myeloma (EMM)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.